August 25, 2021
PARA
WeeklyeJOURNAL NEWS FOR HEALTHCARE DECISION MAKERS
Act em r a: New HCPCS Q0249 Page 8 New FDA Appr oval Page 19
Bon e Void Filler s Page 5 - Respir at or y Ch ar ges Relat ed To COVID - Billing For Hospitalist Nocturnist - Calif or n ia Pr ovider s M on t h ly Updat es - Price Transparency: High Stakes
FAST LINKS
- Rever sin g IPO List s - EUA Amended To Add Another Dose Of COVID Vaccines - FY2022 IPPS Fin al Ru le Redu cin g DSH Paym en t s - Working With BC/BS
- Administration: Pages 1-53 - HIM /Coding Staff: Pages 1-53 - Providers: Pages 2,3,5,8,10,20,31,46 - Respiratory Svcs: Pages 2,31 - COVID Treatment: Pages 1 8,19,22,24,25,43
Is You r Hospit al Leavin g M on ey On Th e Table?
-
Page 7
Finance: Pages 7,27,29 Pharmacy: Pages 19,22,25,43 Quality M gmt: Page 28 California Providers: Page 10 Lab PAM A: Page 35 Pre-Hospital Care: Page 42 Endocrinology: Page 46
© PARA Healt h Car e An alyt ics an HFRI Company CPT® is a r egist er ed t r adem ar k of t h e Am er ican M edical Associat ion
PARA Weekly eJournal: August 25, 2021
RESPIRATORY CHARGES RELATED TO COVID
An external nurse auditor mentioned that she is getting lots of requests from insurers to audit charges for respiratory charges related to COVID. It was something to do with a charge that facilities were adding for respiratory therapy to help bill charges when they were transporting COVID patients. We have not heard of anything here from our respiratory therapy team asking to create a charge. Have you heard of this? Answer: There are no CPT® or HCPCS for an RT?s assistance in transferring patients within the hospital, although hospitals will sometimes invent charges when they are determined to charge for a service, particularly when the charges appear on an inpatient claim. We have been staying abreast of all the new charges created in response to the COVID PHE and publishing them in the COVID-19 Comprehensive Billing & Coding Guide. There have been no reports of a new code to capture the cost associated with the respiratory staff assisting in transporting COVID positive patient from one department to another in the hospital. CMS added 20% to the COVID MS-DRG to account for the extra resources, (e.g., Personal Protective Equipment) needed to care for the COVID positive patient. If you can get a specific code that was referenced by the external nurse auditor, we will research the code to determine its appropriate use. The COVID-19 Comprehensive Billing & Coding Guide can be found on the Advisor Tab by searching the Summary section for ?COVID.?
2
PARA Weekly eJournal: August 25 2021
BILLING FOR HOSPITALIST NOCTURNIST
Our hospitalist/nocturnist coders have come across an issue with billing for both the hospitalist and nocturnist services on the same date of service. Their questions and examples are below. What is your recommendation for coding these services? Now that we employ two nocturnists, we are coming across situations where the nocturnist is seeing the patient in the early morning hours and then the day hospitalist is seeing the patient later in that same day. So, essentially being seen by two hospitalists on the same day. We know we cannot bill two encounters for the same day/same specialty, but we are wondering if we could combine the time between the two visits for leveling and then just bill under one hospitalist, probably the one who initially saw the patient? Is there any way to do a split/share type situation so each provider gets credit for the time they spent with the patient? Here are some examples: Case #1: This patient was admitted on 7/27 at 0130 (per Meditech order), and the nocturnist did an H&P on 7/27 at 0053. On 7/27 at 1549, the hospitalist saw the patient and did a PN. Case #2: This patient was admitted on 7/29 at 2214 (per Meditech order) and the nocturnist did an H&P dated 7/30 at 0045. This patient was discharged on 7/30 at 1031 and the hospitalist did a Discharge Summary dated 7/30 at 1547. Case #3: This patient was admitted on 7/29 at 2226 (per Meditech order) and the nocturnist did an H&P dated 7/30 at 0010. This H&P actually had this at the bottom: "nocturnist Jul 29 2359 but Meditech shows the 7/30 date instead. On 7/30 at 1530, the hospitalist saw the patient and did a PN. Answer: You are correct in stating that you cannot bill two E/M encounters for the same specialty on the same date of service. The Medicare Claims Processing Manual, Chapter 12, 30.6.9, points out that the E/M description includes the phrase ?per day? indicating a Profee E/M can only be billed once daily. Medicare Claims Processing Manual (cms.gov)
3
PARA Weekly eJournal: August 25, 2021
BILLING FOR HOSPITALIST NOCTURNIST
Attached is PARA's paper that goes into more detail about Professional E/M charges. The one topic that is not addressed in the paper is when the nocturnist?s care spans across the midnight hour, as you suspect in some of the examples you shared. The patient was admitted before midnight, care spanned across the midnight hour, then the doctor entered the note after midnight creating an electronic time stamp with a date inconsistent with when the service began. The key to documentation for these E/M services is to have the nocturnist document that the service was continuous and started before midnight so you can bill for the calendar day when the service started. In an MLN Matters, SE17023, the topic of care spanning over the midnight hour states that either date can be used. Using the beginning date would allow for a hospitalist to see the patient later in the day and bill an E/M charge, as long as the hospitalist did not already bill that same date. The hospital should have a clear statement on using either the start date or the end date on all accounts. This would give coders and billers a guideline to follow when determining which date of service to use consistently. se17023 (cms.gov)
If the nocturnist sees the patient after midnight and the hospitalist sees the patient again that same date, (or vice versa) there can only be one E/M charge, unless that second visit is for an unrelated problem as noted in MCPM, Chapter 12, 30.6.5. Again, documentation is key to indicate that the visit was justified due to a new problem.
4
PARA Weekly eJournal: August 25 2021
BONE VOID FILLER C9359 BCBS DENIALS
We have noticed that some of our BCBS claims for the bone void filler and sometimes they do not. We are wanting to know if we are billing these claims correctly. Can you help?
Answer: We don?t recommend a generic code when a more specific code is available and appropriate. In this instance, Blue Cross Blue Shield of North Carolina will not pay for the bone void filler with either code unless it receives prior authorization. BCBS of NC updates their list of codes that require pre-authorization quarterly. Porous purified collagen matrix bone void filler (C9359) was added to this list with an effective date of October 1, 2020.
PPA-Service-Code-List.pdf (bluecrossnc.com)
5
PARA Weekly eJournal: August 25, 2021
BONE VOID FILLER C9359 BCBS DENIALS
In reviewing the EOP you attached to the task, the Remark Code ?W18? is listed with $0.00 reimbursement, which is defined as ?Prior Plan approval not obtained. Provider responsible for charges.? This product should be flagged as requiring preauthorization for all BCBS beneficiaries. You can seek retro-authorization on claims with service dates after October 1, 2020.
6
PARA Weekly eJournal: August 25 2021
WEBCAST: ZERO BALANCE INSURANCE AR
Is Your Hospit al Leaving Money On The Table? How would you know? We can tell you. Sign up for our webinar on Wednesday, August 25, 2021 where we will discuss how zero balance insurance AR could be a beneficial untapped revenue stream for your organization to pursue. Webinar Topics Include: - Revenue risks that exist in zero balance AR - The limitations of contract management solutions - Expert recovery that goes directly to your bottom line - Preventing future risks, and - Minimizing uncollected zero balance review through strong AR follow up. Sign up today! https://reg.xtelligentmedia.com/2021-825HFRWebcast_Unique
7
PARA Weekly eJournal: August 25, 2021
ACTEMRA UPDATE: CMS HCPCS Q0249 TOCILIZUMAB
THIS UPDATE INFORMS READERS OF NEW HCPCS Q0249 The FDA Emergency Use Authorization (EUA) for tocilizumab (Actemra®) in treating hospitalized patients with COVID-19 is limited to administration of the drug via IV therapy. The previously established HCPCS J3262 is inappropriate for reporting IV tocilizumab used under the EUA. CMS created HCPCS Q0249 (short descriptor: Tocilizumab for covid-19) on June 24, 2021 in order to allow facilities to report the drug on Part B only inpatient claims, and claims for hospitalized patients under observation (Inpatient services billed on the TOB 11X do not require HCPCS codes.) HCPCS for subcutaneous tocilizumab, J3262, is not appropriate when reporting IV administration. https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnershipemail-archive/2021-07-22-mlnc#_Toc77687195
On June 24, 2021, the FDA issued an Emergency Use Authorization (EUA) for treatment of COVID-19 in hospitalized patients with the drug tocilizumab (Actemra): https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-andpolicy-framework/emergency-use-authorization#coviddrugs
8
PARA Weekly eJournal: August 25 2021
ACTEMRA UPDATE: CMS HCPCS Q0249 TOCILIZUMAB
The ICD-10 codes for reporting tocilizumab on an inpatient claim are XW033H5 and XW043H5:
The subcutaneous version of Acetmra is not authorized for use in treating COVID-19 patients.The FDA Fact Sheet for Healthcare Providers: Emergency Use Authorization for Actemra (tocilizumab) states: https://www.fda.gov/media/150321/download
Some clients have inquired shortages of Actemra; the FDA suggests contacting the drug manufacturer for assistance:
The customer service phone line for Genentech is(800) 551-2231, available M-F 6 a.m. 0 5 pm Pacific time, according to the Genentech website: https://www.gene.com/contact-us/call-us
9
PARA Weekly eJournal: August 25, 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
AUG
The following services have been detailed in the associated Bulletins -https://files.medi-cal.ca.gov/ pubsdoco/Bulletins_ menu.aspx
- Allied Health Acupuncture (ACU) Audiology and Hearing Aids (AUD) Chiropractic (CHR) Durable Medical Equipment and Medical Supplies (DME) Medical Transportation (MTR) Orthotics and Prosthetics (OAP) Psychological Services (PSY) Therapies (THP) - Inpatient / Outpatient Inpatient Services (IPS) Community?Based Adult Services (CBAS) AIDS Waiver Program (AID) Clinics and Hospitals (CAH) Chronic Dialysis Clinics (DIA)
10
PARA Weekly eJournal: August 25 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
Inpatient / Outpatient, con't. Heroin Detoxification (HER) Home Health Agencies/Home & Community-Based Services (HOM) Hospice Care Program (HOS) Local Educational Agency (LEA) Multipurpose Senior Services Program (MSSP) Rehabilitation Clinics (REH) - Long Term Care https://files.medi-cal.ca.gov/pubsdoco/bulletins/artfull/ltc202107.aspx - Medical Services General Medicine (GM) Obstetrics (OB) - Pharmacy ? https://files.medi-cal.ca.gov/pubsdoco/bulletins/artfull/ph202107r.aspx - Vision Care ? https://files.medi-cal.ca.gov/pubsdoco/bulletins/artfull/vc202107.aspx - Family PACT ? https://files.medi-cal.ca.gov/pubsdoco/bulletins/artfull/fpact202107.aspx The July 2021 Clinics and Hospitals Medi-Cal Update is located: https://files.medi-cal.ca.gov/ pubsdoco/bulletins/artfull/cah202107.aspx
11
PARA Weekly eJournal: August 25, 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
All participating Medi-Cal Program providers: COVID-19 expired waiver for in-person signature requirement for delivered medications: Effective on April 28, 2020, a waiver was placed related to providers who dispense controlled drugs, dangerous drugs or dangerous devices to a Medi-Cal beneficiary due to the COVID-19 PHE. Effective July 01 2021, this waiver will no longer be in effect. Providers will be required to obtain beneficiary signatures for medications in person from their home or sign onsite at the provider?s location. Update: Rates for Hormone Containing Vaginal Rings: Effective for dates of service on or after April 01, 2021, rates have been updated for claims reporting HCPCS code J7303 and modifier U1 or U2 as follows:
Update: Radiology Reimbursement: Effective retroactively for dates of service on or after January 01, 2019 and January 01, 2020, radiology reimbursement rates have been adjusted. DHCS adjusted radiology reimbursement rates, so they do not exceed 80% of the corresponding Medicare rate. No action is required from providers for this adjustment, an Erroneous Payment Correction will be implemented to reprocess impacted provider claims. Clinics and Hospitals, General Medicine, Obstetrics: Update: Minimum Age Limit for Colorectal Screening: Effective for dates of service on or after May 18, 2021, CPT® code 81528 has an updated minimum age limit of 45 years of age. An Erroneous Payment Correction will be implemented to reprocess denied claims. Providers may elect to use this updated policy to resubmit previously denied claims.
12
PARA Weekly eJournal: August 25 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
Clinics and Hospitals, General Medicine, Obstetrics, Rehabilitation Clinics, Chronic Dialysis Clinics, Pharmacy: New Benefit ? Sotrovimab for COVID-19: Effective for dates of service on or after May 26, 2021, the FDA has authorized Sotrovimab for the treatment of COVID-19 under an Emergency Use Authorization (EUA). Sotrovimab must be purchased by providers who must bill and be reimbursed for the cost of the product. Providers who bill for the cost of the administration report applicable administration HCPCS - Q0247- injection, sotrovimab, 500 mg - M0247- intravenous infusion, sotrovimab, includes infusion and post administration monitoring - M0248- INTRAVENOUS INFUSION, SOTROVIMAB, INCLUDES INFUSION AND POST administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
13
PARA Weekly eJournal: August 25, 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
Clinics and Hospitals, General Medicine, Obstetrics, Chronic Dialysis Clinics, Pharmacy, Rehabilitation Clinics, Inpatient Services: Update: Allowable Specialized Services? Effective for dates of service on or after July 01, 2021, the list of specialized services that can be billed on an outpatient claim, even when provided on an inpatient basis, has been updated to reflect the following: Existing policy in place shall remain in place for all other allowable specialized services.
14
PARA Weekly eJournal: August 25 2021
CALIFORNIA MEDI-CAL MONTHLY UPDATES
Clinics and Hospitals, General Medicine, Obstetrics providers that participate in the Medi-Cal Every Woman Counts (EWC) Program: New Benefit ? Telehealth Services? Effective retroactively for dates of service on or after November 01, 2013, HCPCS code Q3014 and T1014 are new benefits to the Medi-Cal EWC Program.
15
PARA Weekly eJournal: August 25, 2021
PRICE TRANSPARENCY COMPLIANCE: THE STAKES JUST GOT HIGHER
CM S ju st r aised t h e st akes on Pr ice Tr an spar en cy com plian ce. Don't r oll t h e dice on t h e n ew civil m on et ar y pen alt ies. On May 3, 2021, the American Hospital Association (AHA) released a M ember Advisory regarding noncompliance with the Centers for Medicare & Medicaid Services?(CMS) Hospital Price Transparency requirements.In it, they note that CMS has launched proactive audits of hospital websites and have evaluated complaints presented to CMS by consumers. According to the publication, CMS started with auditing larger acute care hospitals and have now expanded their examination of random hospitals.The first set of warning letters were issued the week of April 19th.However, CMS has indicated that they will not announce the list of hospitals that have received warning letters but will publish the identities of the hospitals that remain non-compliant and receive a monetary penalty if they have not addressed the issues within 90 days.
Nu m ber Of Hospit al Beds
M axim u m An n u al Civil M on et ar y Pen alt y
<30
$109,500
50
$182,500
100
$365,000
200
$730,000
300
$1,095,000
400
$1,460,000
500
$1,825,000
550+
$2,007,500
The PARA Price Transparency Solution is so effective, that clients are indemnified from any civil monetary penalty. There's no risk with PARA.
16
PARA Weekly eJournal: August 25 2021
PRICE TRANSPARENCY COMPLIANCE: THE STAKES JUST GOT HIGHER
The July 19, 2021 mlnconnects Special Edition states that CMS is updating the civil monetary penalty amount.The current minimum civil monetary penalty of $300/day would apply to smaller hospitals with less than 30 patient beds.However, for hospitals with more than 30 beds, the penalty will be $10/bed/day, not to exceed a maximum daily dollar amount of $5,500. ?Under this proposed approach, for a full calendar year of noncompliance, the minimum total penalty amount would be $109,500 per hospital, and the maximum total penalty amount would be $2,007,500 per hospital.? [mln connects Special Edition] PARA HealthCare Analytics, an HFRI Company, is among the leaders in supporting hospitals in achieving readiness for CMS Price Transparency regulations, which will help consumers make more informed healthcare purchasing decisions. To ensure consumers will be able to browse for healthcare services in the same way they shop for other goods and services online, PARA has developed robust and accurate pricing capabilities for area healthcare consumers. The PARA solution includes a patient-facing estimator that delivers user-friendly, procedure-level estimates reflecting patients?specific coverage limits and is updated quarterly for the facility. As a reminder, the CMS Hospital Price Transparency rule requires that hospitals publish detailed pricing information online to help consumers make accurate cost comparisons for a range of treatments and procedures. The rule contains two types of price transparency requirements: - Hospitals must post their entire array of standard charges online in a machine-readable file that is easily accessible from their public website - Hospitals must publish a document listing pricing for 300 specific shoppable healthcare services. Of these 300 items, 70 have been pre-defined by CMS, while the remaining 230 can be selected at the discretion of the hospital. For both requirements, a range of different price categories must be shown, including gross charges, payer-specific negotiated rates, self-pay discounted rates, and de-identified minimum and maximum negotiated charges. The files also must contain any ancillary charges that are customarily included for the specific shoppable service, such as the costs associated with additional related procedures, tasks, allied services, supplies, or drugs, as well as any professional fees billed separately from the facility bill. These requirements present challenges when it comes the sheer data mining and payer contract analytics required to deliver on the mandates. PARA?s payer contract models accommodate a variety of settlement methodologies by patient type including MS-DRG, APR-DRG, EAPG, ASC Levels, APC packaging, and percent of charge, among others. For a typical hospital with a 10,000-line chargemaster, seven patient types, and 20 payer contracts, this could mean 1.4M calculations needed to fulfill the mandate.According to an HFM A Article on the topic, this detailed approach could cost a hospital several hundred thousand dollars to contract with a consulting firm.
17
PARA Weekly eJournal: August 25, 2021
PRICE TRANSPARENCY COMPLIANCE: THE STAKES JUST GOT HIGHER However, PARA's Price Transparency Tool, which uses the actual payer contract language as outlined in the CMS requirements to make those millions of calculations, costs under $30,000 in the first year, with nominal (under $3,000) quarterly maintenance fees thereafter. It is the most cost-effective and comprehensive solution out there today. Consumers expect to shop for healthcare the same way they shop for other goods and services and healthcare providers must be ready to meet that need. Therefore, PARA HealthCare Analytics, an HFRI Company, has partnered with hospitals across the nation to empower them in providing this required information in a consumer-friendly, intuitive manner. The team at PARA believes that price transparency and Patient Price Estimators are a useful and important component of healthcare consumerism and have spent the past year preparing for the release of these requirements. In speaking with hospital associations, clients, and business vendor groups, we are finding that we are one of the only vendors who can completely satisfy, to the spirit and letter of the law, both CMS requirements in a fully customizable manner.
To f in d ou t m or e abou t ou r solu t ion , please con t act on e of ou r exper t s. San dr a LaPlace
Violet Ar ch u let -Ch iu
Account Executive
Senior Account Executive
splace@para-hcfs.com
varchuleta@para-hcfs.com
800.999.3332 x 225
800.999.3332 x219 18
PARA Weekly eJournal: August 25 2021
PFIZER COVID VACCINE COMIRNATY GRANTED FULL FDA APPROVAL
On August 23, 2021, the FDA approved licensing of the Pfizer COVID-19 vaccine. Marketed as Comirnaty (COVID-19 Vaccine, mRNA), the vaccine approval covers coronavirus prevention for ages 16 and older. An Emergency Use Authorization (EUA) remains in place for ages 12 through 15.The EUA also covers a third dose for solid organ transplant recipients and those with immunocompromised conditions. The FDA offers a Fact Sheet through the following link: https://www.fda.gov/media/144413/download
19
PARA Weekly eJournal: August 25, 2021
CMS REVERSING IPO LIST AND ASC CPL IN 2022 OPPS PROPOSED RULE
In the 2022 OPPS proposed rule, CMS proposes to reverse two of the 2021 policies that some hospital stakeholders had opposed; the phase-out of the inpatient-only (IPO) list and relaxing criteria for adding services to the ambulatory surgical center covered-procedures list (ASC CPL.) A copy of the proposed rule is available on the Advisor tab of the PARA Data Editor; search ?2022?:
Inpatient only-- The 298 inpatient-only procedures that were being phased out under the 2021 OPPS rule would be added back to the IPO list under the 2022 OPPS proposed rule. CMS will be soliciting further comments on whether they should maintain the longer-term objective of eliminating the IPO list or maintain the IPO list but continue to systematically scale the list back. CMS also proposes to shorten the exemption from medical review activities for services removed from the IPO list to two years. CY 2022 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS-1753-P) | CMS
20
PARA Weekly eJournal: August 25 2021
CMS REVERSING IPO LIST AND ASC CPL IN 2022 OPPS PROPOSED RULE
Ambulatory surgical center covered-procedures-- CMS is proposing to reinstate the ASC CPL criteria that was in effect in CY 2020 and remove 258 of the 267 procedures that were added to the ASC CPL in CY 2021. CMS is requesting comments on whether any of the 258 procedures meet the CY 2020 criteria they are proposing to reinstate. They are also proposing to change the notification process adopted in CY 2021 to a nomination process, under which stakeholders could nominate procedures they believe meet the requirements to be added to the ASC CPL. The formal nomination process would begin in CY 2023.
In addition to the IPO list and ASC CPL changes, the proposed rule addresses the health equity gap and fighting the Covid-19 PHE. The rule will also be promoting safe, effective, and patient-centered healthcare through proposals that affect the newly established Rural Emergency Hospital provider type, partial hospitalization programs, and the Radiation Oncology Model. The new rule also includes proposals to encourage transparency in health systems. PARA HealthCare Analytics, a leader in supporting hospitals in achieving readiness for CMS Price Transparency regulations, will be following these proposals closely.
21
PARA Weekly eJournal: August 25, 2021
EUA AMENDED TO ADD ANOTHER DOSE OF COVID VACCINES
On August 12, 2021, the FDA announced in a press release that they amended the EUA for the Pfizer and Moderna COVID-19 vaccines.The amendment allows solid organ transplant recipients and individuals diagnosed with conditions considered immunocompromised to receive an additional dose of the vaccines. The FDA also states that, at this time, fully vaccinated people do not need an additional dose. People with immunocompromised conditions are more vulnerable to COVID-19 and other infections.The FDA evaluated data and determined that an additional COVID-19 vaccine may protect this small, vulnerable group of people. The announcement also recommends that if an immunocompromised person is exposed to or contracts COVID-19, they should consult a healthcare provider to determine if they may need monoclonal antibody therapy. The AMA provided the following HCPCS codes in response to the amended EUA: https://www.ama-assn.org/press-center/press-releases/ama-announces-cpt-code-set-ready-thirddoses-covid-19-vaccines
Medicare will cover the additional doses with approximately $40 administration fee as they have the first and second COVID-19 vaccine doses. https://www.cms.gov/newsroom/news-alert/people-medicare-who-are-immunocompromisedwould-be-able-receive-additional-covid-19-dose-no-cost
22
PARA Weekly eJournal: August 25 2021
EUA AMENDED TO ADD ANOTHER DOSE OF COVID VACCINES
The August 12, 2021 FDA announcement is available through the following link: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdaauthorizes-additional-vaccine-dose-certain-immunocompromised
23
PARA Weekly eJournal: August 25, 2021
FDA TO WITHDRAW EUA ON COVID PCR TEST DECEMBER 31, 2021
On July 21, 2021, the CDC announced it will withdraw its Emergency Use Authorization (EUA) request for the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel after December 31, 2021. The advanced notice allows laboratories to adopt and prepare to use an alternative FDA approved test. The 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel detects only COVID-19.The CDC suggests laboratories begin using a multiplex assay that can detect both COVID-19 and influenza, which will be save time and laboratory resources as we enter flu season. https://www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_ RT-PCR_SARS-CoV-2_Testing_1.html
24
PARA Weekly eJournal: August 25 2021
FDA AUTHORIZES TOCILIZUMAB RX FOR INPATIENT COVID-19
On Ju n e 24, 2021, t h e FDA issu ed an Em er gen cy Use Au t h or izat ion (EUA) f or t r eat m en t of COVID-19 in h ospit alized pat ien t s w it h t h e dr u g t ocilizu m ab (Act em r a ® ):
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policyframework/emergency-use-authorization#coviddrugs
The ICD-10 codes for reporting tocilizumab on an inpatient claim are XW033H5 and XW043H5:
25
PARA Weekly eJournal: August 25, 2021
FDA AUTHORIZES TOCILIZUMAB RX FOR INPATIENT COVID-19
PARA Data Editor users may find the NDC?s and HCPCS assigned to Tocilizumab on the Calculator tab by searching ?tocilizumab? or ?Actemra? using the ?NDC to J-Code Crosswalk? report:
As of July 29, 2021, the ICD10 codes for Tocilizumab are not on the list of codes qualifying an inpatient claim for enhanced DRG reimbursement under Medicare?s ?New COVID-19 Treatments Add-On Payment? program (NCTAP). https://www.cms.gov/medicare/covid-19/new-covid-19-treatments-add-payment-nctap
If and when CMS adds the ICD10 codes for tocilizumab to the NCTAP program, PARA will update this article.
26
PARA Weekly eJournal: August 25 2021
FY2022 IPPS FINAL RULE - REDUCED DSH PAYMENTS
Among other changes Medicare made to the Inpatient Prospective Payment System (IPPS) in the 2022 Final Rule, payments to qualifying hospitals under the Disproportionate Share (DSH) program will be reduced by $1.2 billion across all providers.Under IPPS, Medicare pays a fixed amount per discharge for hospitals eligible for Disproportionate Share payments. The DSH rate does not vary by DRG weight, it is a static value calculated for each hospital (note ? this does not apply to Critical Access Hospitals, which are not paid under IPPS.) The Final Rule can be located on the CMS website at the link below: https://www.cms.gov/medicare/acute-inpatient-pps/fy-2022-ipps -final-rule-home-page
The specific impact of the reduction in DSH payments has been calculated by PARA and posted to the PARA Data Editor Advisor tab. We inserted a new column AG to the CMS FY2022 IPPS Final Rule Impact File, which cell contains the difference between the FY2021 DSH payment rate from column AF (UCP Per Claim Amount LY) and the 2022 DSH rate published in column AD (UCP Per Claim Amount.)
PARA Data Editor users will find PARA?s worksheet on the Advisor tabby searching for ?2022? in the Summary field:
27
PARA Weekly eJournal: August 25, 2021
CMS PROPOSES CHANGES TO HOSPITAL QUALITY MEASURES
Within the 2022 OPPS Proposed Rule, CMS has proposed two new quality measures for hospitals which, if adopted, will factor into OPPS reimbursement rates for the individual hospitals in future years. The full proposed rule has been published in the Federal Register publication at the link below: https://www.federalregister.gov/documents/2021/08/04/2021-15496/medicare-programhospital-outpatient-prospective-payment-and-ambulatory-surgical-center-payment Newly proposed measures include: - For payment determinations in calendar year 2024 -- COVID-19 Vaccination Coverage Among Health Care Personnel (HCP); the measure data will begin with the CY 2022 Reporting Period, but the results will be reflected in the CY 2024 Payment Determination.The COVID-19 Vaccination Coverage Among HCP measure will track COVID-19 vaccination coverage in non-LTC facilities including outpatient hospitals.The numerator for the HCP measure is the number of HCP eligible to work in at the hospital for at least 1 day during a certain week (self-selected per quarter) and who received a complete COVID-19 vaccination. The discussion of this measure begins on page 1509 of the proposed rule: https://www.federalregister.gov/d/2021-15496/p-1509 - For payment determinations in CY 2023: Breast Screening Recall Rates?which measures the percentage of Medicare beneficiaries for whom a traditional mammography or Digital Breast Tomosynthesis (DBT) screening study was performed that was then followed by a diagnostic mammography, DBT, ultrasound of the breast, or magnetic resonance imaging (MRI) of the breast in an outpatient or office setting on the same day or within 45 calendar days of the index image. Data will be used from July 1, 2020 through June 30, 2021, and annually July 1 through June 30 thereafter.CMS intend for this measure to move facilities toward the 5 to 12 percent range of recall rates.The discussion of this measure begins on page 1581 of the proposed rule: https://www.federalregister.gov/d/2021-15496/p-1581 CMS also proposes to remove two measures beginning with the 2023 reporting period and 2025 payment determination: - OP-2 (Fibrinolytic Therapy Received Within 30 Minutes Of ED Arrival) And - OP-3 (Median Time To Transfer To Another Facility For Acute Coronary Intervention) The proposed quality measures to be removed are discussed beginning on page 1501: https://www.federalregister.gov/ d/2021-15496/p-1501 28
PARA Weekly eJournal: August 25 2021
FIVE TIPS TO WORKING WITH BLUE CROSS/BLUE SHIELD OF ILLINOIS
A health insurance company as prominent as Blue Cross Blue Shield (BCBS), having over 62 million members across all 50 states, provides high potential for revenue generating opportunities for any hospital Central Billing Office (CBO). According to the 2020 census, there are 12.8 million people living in the state of Illinois with 80 percent of that population enrolled with BCBS of Illinois. Based on these statistics, that would suggest that 10.2 million residents in Illinois are enrolled for healthcare coverage through BCBS. In terms of a business perspective on a revenue standpoint, BCBS of Illinois coverage should always be a high focus for any facility solely for the revenue aspect when patients are seen. Tip 1: Understanding your EDI clearinghouse All hospitals throughout Illinois should have an intimate understanding of what is required from front-end registration to denial management to streamline revenue as best as possible for this large number of insured individuals with one carrier. BCBS of Illinois requires the use of an insurance web portal or clearinghouse, so it is important to understand the range of products that portal provides. This will help maximize efficiency and avoid unnecessary denials to keep aging clean and healthy for this large volume carrier. Tip 2: Checking eligibility ? the key to clean claims On a front-end/registration point of view, utilizing running eligibility is a simple starting point to ensure your claims are being sent to the appropriate address. Whether a patient?s coverage is through an Independent Practice Association (IPA), Managed Care Organization (MCO), Labor Fund, Federal or traditional BCBS, checking eligibility is the first step to avoid any unnecessary submissions or claim status inquiry attempts. Tip 3: Utilizing AIM to help decrease denials After eligibility is confirmed and the patient?s benefits based on the services have been provided, utilizing the AIM portal within the insurance web portal is another excellent tool for preauthorization purposes. The AIM portal allows you to look up the services a patient is scheduled to receive and verify if that specific CPT® code requires a preauthorization. As a vendor, the most common denials we see with our hospitals are specifically from the clinical denial aspect. This denial category would pertain to no authorization, medical necessity, level of care, and length of stay. With utilizing the AIM portal, this will provide an opportunity to minimize no authorization denials with a simple check if the scheduled services require an authorization or not. If your facility is not aware of this, please reach out to your provider representative to provide you this information. On a medical necessity standpoint, you may also utilize the AIM portal to initiate a peer-to-peer review for level of care or length of stay denials in efforts to overturn these denials received. 29
PARA Weekly eJournal: August 25, 2021
FIVE TIPS TO WORKING WITH BLUE CROSS/BLUE SHIELD OF ILLINOIS
Tip 4: Improving follow-up efficiency and accuracy Follow-up efficiency and accuracy is also important when dealing with this high-volume carrier. With roughly 10.2 million members, traditional BCBS of Illinois receives enormous amounts of calls a day regarding claim status inquires. Using an insurance web portal?s claim status tool for all claim status inquires prior to calling can help reduce unnecessary calls. This tool provides the opportunity to capture all key and necessary information needed to grasp a rough understanding of all claim status inquires. There may be times that the information captured may not be sufficient in terms of a progressive standpoint to verify if recent submitted disputes or documents are under review. Utilizing the CIR, or Claim Inquiry Resolution tool, is another effective way to verify an updated status of documents or disputes submitted, which is provided with a reference number for tracking purposes to ensure all inquiries are answered in a timely manner. Utilizing this tool helps reduce call volumes along with decreased hold times. Not only will this tool assist the efficiency of any CBO staff member but will also help vendors as well. Tip 5: Understanding contractual reimbursement agreements Some believe that BCBS pays at 100% of billed charges when in fact that is not the case. Typically, what happens is that it appears payments are paid in full within an Electronic Medical Records (EMR) system but in reality, the contractual adjustment is applied on the back end through the UPP Program. The Uniform Payment Program (UPP) in a sense is the contractual reimbursement solely for BCBS and individual facilities. The UPP discount can range from 25 percent to 70 percent based on services provided or the facility in general. It is encouraged to speak to your provider representative or your internal contract management department if you do not have a clear understanding of the discount BCBS of Illinois has with your facility. Streamlining BCBS accounts In conclusion, BCBS of Illinois provides countless opportunities to streamline this book of business with your CBOs and your vendors to help improve efficiencies which in turn will increase your revenue. Accurately utilizing all tools that BCBS and an insurance web portal provide is another opportunity to decrease denial volumes thus reduce aging. Any specific questions you may have, it is highly encouraged to reach out to your provider representative that will allow you to make your CBO and vendors more successful.
30
PARA Weekly eJournal: August 25 2021
PULMONARY REHAB COVERAGE FOR CHRONIC COVID-19 PROPOSED In the 2022 Medicare Physician Fee Schedule (MPFS) Proposed Rule, CMS indicates it intends to expand coverage of outpatient pulmonary rehabilitation (PR) to include beneficiaries experiencing persistent respiratory symptoms after being hospitalized with COVID-19. As specified in 42 CFR 410.47, Medicare currently covers pulmonary rehab services for patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).
The 2022 MPFS proposed rule would add pulmonary rehab coverage for Medicare beneficiaries who have been diagnosed with severe manifestations of COVID?19, defined as requiring hospitalization in the ICU or otherwise, and who experience continuing symptomatology, including respiratory dysfunction, for at least 4 weeks post discharge. In clarifying the definition of persistent respiratory symptoms, the CDC uses the term post-COVID conditions to describe health issues that persist more than four weeks after first being infected with the causative virus. Similarly, the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN), and the Royal College of General Practitioners (RCGP) have jointly used four weeks to differentiate the acute symptoms of COVID. Based on the information from the CDC, NICE, SIGN, and RCGP, CMS considers COVID?19 to be chronic when symptoms persist for more than 4 weeks. Symptoms include dyspnea, depression, and anxiety which can impair physical function and cause incapacitation.The clarification can be found on page 155 in the Federal Register, Vol. 86, No. 139, published, Friday, July 23, 2021. A link to a PDF file with the full proposed rule is available on the PARA Data Editor Advisor tab; search ?2022? in the summary field:
31
PARA Weekly eJournal: August 25, 2021
CMS REMOVES CERTAIN NCDS -- DEFERS COVERAGE TO MACS
In an MLN dated August 2, 2021, CMS announced that effective January 1, 2021, it has removed several older National Coverage Determinations (NCDs) that may have become obsolete or unnecessary.The agency has deferred coverage decisions on the services previously addressed in these NCDs to the judgement of the MACs. MACs may decide to cover services previously covered, or to continue non-coverage as previously established in the NCD. https://www.cms.gov/files/document/mm12254.pdf
The 2021 Payment Policies under the Medicare Physician Fee Schedule and other Part B services were published in the Federal Register on December 28, 2021 ? a pertinent excerpt is provided: https://www.govinfo.gov/content/pkg/FR-2020-12-28/pdf/2020-26815.pdf#page=326 J. Removal of Selected National Coverage Determinations In the CY 2021 PFS proposed rule (85 FR at 50255), we proposed to use the notice and comment rulemaking to identify and remove older NCDs that we believed no longer contained clinically pertinent and current information or no longer reflected current medical practice. ? Instead, in the absence of an NCD, the coverage determinations for those items and services would be made by Medicare Administrative Contractors (MACs). We also noted that if the previous NCD barred coverage for an item or service under title XVIII (that is, national noncoverage NCD), a MAC would now be able to cover the item or service if the MAC determined that such action was appropriate under the statute. Removing a national non-coverage NCD may permit access to technologies that may be beneficial for some uses. We explained that as the scientific community continues to conduct research producing new evidence, the evidence base we previously reviewed may have evolved to support other policy conclusions. In the proposed rule, we also described the circumstances that we had used in determining whether an older NCD should be removed. 32
PARA Weekly eJournal: August 25 2021
COVID-19 UPDATE PARA Healt h Car e An alyt ics continues to update COVID-19 coding and billing information based on frequently changing guidelines and regulations from CMS and payers. All coding must be supported by medical documentation.
Download the updated Guidebook by clicking here. 33
Updat ed An d Revised Au gu st 17, 2021
PARA Weekly eJournal: August 25, 2021
Expanded PDE Training Sessions Available PARA offers nationwide overview training on the PARA Data Editor each week. And, due to increased demand, we are expanding the training schedule to include sessions that focus on the two most frequently used modules with the PDE. Sessions on Charge Quote and the Calculator will now be offered on Tuesdays (Charge Quote) and Thursdays (Calculator) at the following times: Tuesdays: 11:00 am Pacific Daylight Time Thursdays: 8:00 am Pacific Daylight Time Regular PDE Training Sessions: Wednesdays at 11:00 am PDT and Fridays at 8:00 am PDT
I nterested? Please contact one of the following experts for a session key.
Mary McDonnell: 800.999.3332, ext 216 mmcdonnell@para-hcs.com Violet Archuleta-Chiu: 800.999.3332, ext 219 varchuleta@para-hcfs.com Sandra LaPlace: 800.999.3332, ext 225 slaplace@para-hcfs.com Gail Langord: 800.999.3332, ext 426 glangford@para-hcs.com Randi Brantner: 800.999.3332, ext 215 rbrantner@para-hcfs.com 34
If you can't make any of these sessions, but would still like to attend, please contact Mary McDonnell for options.
PARA Weekly eJournal: August 25 2021
JULY 2021 LAB PAMA ISSUES
TI M E
LIKE SANDS THROUGH THE HOURGLASS, THE TIME TO COMPLY IS RUNNING OUT.
LAB PAM A
DETAILED GUIDANCE BOOKLET TIM ELINES AND REQUIREM ENTS
Pr icin g | Codin g | Reim bu r sem en t | Com plian ce 35
PARA Weekly eJournal: August 25, 2021
Introduction
Congress instructed Medicare to set its rates under the Clinical Lab Fee Schedule at the weighted median of private payer rates.
"
BACKGROUND
PAMA stands for Pr ot ect in g Access t o M edicar e Act of 2014 and was published by The White House Office of Management and Budget to modify the Medicare reimbursement rate methodology for lab services.
In doing so, Congress hoped to ensure Medicare did not overcompensate providers for lab services, protecting the Medicare program by saving money while compensating providers at a defensible rate of reimbursement per laboratory diagnostic test. .
36
PARA Weekly eJournal: August 25 2021
Private payer rate reporting is required of so-called ?Applicable laboratories.? A hospital lab likely qualifies as an ?Applicable Laboratory? if it earned more than $12,500 in reimbursement from Medicare for ?outreach? lab services billed on the 014X (non-patient services) type of bill and paid between January 1 and June 30, 2019. Although there are several tests, the revenue threshold test is the most pivotal determination as it pertains to hospital laboratories.
"
Wh at 's An Applicable Lab? Hospital Labs Serving:
-
- Inpatients - Outpatients - Non-Patients (?Outreach?)
-
Physician Office Labs Performing: - Point of Care/Traditional Tests - Provider-Performed Microscopy - Pathologists?Practices Independent Labs Performing:
-
- Standard Tests - Drug Abuse Testing - Molecular Diagnostics 37
A CLIA certified laboratory that bills Medicare Part B under it?s own NPI or under the hospital?s NPI And received the majority of the payments for non-patient services (TOB 14X) paid by Medicare in the first 6 months of 2019 under the CLFS or MPFS (a given for hospital outreach labs) And received more than $12,500 in payments from Medicare for TOB 14X services between 1/1/19 and 6/30/19
PARA Weekly eJournal: August 25, 2021
Hospital laboratories which offer ?outreach laboratory? services process specimens collected by another provider without actually seeing the patient in person. Such ?specimen only? testing is submitted to Medicare and non-Medicare payers on the 014X (non-patient services) Type of Bill (TOB.)
JUST THE FACTS, PLEASE
PAMA requires CMS to set the rates paid under its Clinical Lab Fee Schedule at the weighted median rate of payment that private payers pay for each specimen-only lab test. Consequently, CMS must compel certain ?applicable laboratories?, including certain hospitals and physician clinics, to periodically report the payment rates each provider received for non-patient lab services billed to commercial and managed care payers. CMS will use data collected from the first six month of 2019 to set the Clinical Lab Fee Schedule (CLFS) rates for 2023 through 2025. The current CLFS rates, which many providers complain are too low, were calculated from data submitted by a small number of national and regional labs in 2016. Going forward, more providers of non-patient laboratory services will be required to report payment rates to be used in calculating the CLFS. CMS efforts to communicate the data reporting requirement have been muddled with excruciating detail, causing the requirement to be widely misunderstood. In an effort to clarify the requirement as the deadline for reporting approaches, CMS published a ten-page ?summary? document and a new FAQ on April 20, 2021, at the links on the next page. 38
PARA Weekly eJournal: August 25 2021
https://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/ClinicalLabFeeSched/Downloads/ CY2019-CLFS-PrivatePayor-RateBased-Summary.pdf https://www.cms.gov/files/document/frequently-asked -questions-cy-2021-clfs.pdf Hospitals which received more than $12,500 in Medicare revenues for non-patient lab services paid between 1/1/209 and 6/20/2019, will likely meet the definition of an ?applicable laboratory?, which triggers the requirement to report private payer rates early next year. Applicable laboratories must report each CLFS CPT® , each payment rate, and the quantity of times each rate was paid for a non-patient service billed to commercial and Medicare or Medicaid managed care payers; reports must be submitted online through the CMS PAMA reporting website in early 2022.Failure of an applicable laboratory to report carries a risk of substantial penalties. While data was initially collected from a few national lab providers in 2016, Medicare has expanded the definition of ?Applicable Laboratories? since then to include certain hospitals and physician practices. Payment reporting requirement is burdensome and confusing, but PARA can help you determine whether your facility qualifies as an ?applicable lab? and in preparing the data for submission.
39
THE COST OF NON-COM PLIANCE
PARA Weekly eJournal: August 25, 2021
?We are revising the certification and CMP (Civil Monetary Penalties) policies in the final rule to require that the accuracy of the data be certified by the President, CEO, or CFO of the reporting entity, or an individual who has been designated to sign for, and who reports directly to such an officer.
CURRENT CM P $10,017 Per Day
40
PARA Weekly eJournal: August 25 2021
PARA has developed a 30-minute online presentation that can help keep you compliant with PAMA laboratory rate and reporting requirements. It's vital information for all clinical laboratories.
Click t he m on it or t o w at ch .
Th en con t act you r PARA Accou n t Execu t ive f or det ails. Ran di Br an t n er
San dr a LaPlace
Violet Ar ch u let -Ch iu
Vice President of Analytics
Account Executive
Senior Account Executive
rbrantner@hfri.net
splace@para-hcfs.com
varchuleta@para-hcfs.com
719.308.0883
800.999.3332 x 225
800.999.3332 x219
41
PARA Weekly eJournal: August 25, 2021
MLN CONNECTS
PARA invites you to check out the mlnconnects page available from the Centers For Medicare and Medicaid (CMS). It's chock full of news and information, training opportunities, events and more! Each week PARA will bring you the latest news and links to available resources. Click each link for the PDF!
Th u r sday, Au gu st 19, 2021
New s -
Immunization: Medicare Covers Vaccines
Com plian ce -
Chiropractic Services: Comply with Medicare Billing
Requirements
Even t s -
Medicare Ground Ambulance Data Collection System: Instrument Walkthrough Webinar ? August 26 Medicare Ground Ambulance Data Collection System: Q&A Session ? September 14
M LN M at t er s® Ar t icles -
-
Implementation of the Capital Related Assets Adjustment (CRA) for the Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Under the End Stage Renal Disease Prospective Payment System (ESRD PPS) Implementation of the GV Modifier for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) for Billing Hospice Attending Physician Services Inpatient Psychiatric Facilities Prospective Payment System (IPF PPS) Updates for Fiscal Year (FY) 2022 Inpatient Rehabilitation Facility (IRF) Annual Update: Prospective Payment System (PPS) Pricer Changes for FY 2022 Medicare Part A Skilled Nursing Facility (SNF) Prospective Payment System (PPS) Pricer Update FY 2022 Modifications/Improvements to Value-Based Insurance Design (VBID) Model ? Implementation Skilled Nursing Facility (SNF) Claims Processing Updates Update of Internet Only Manual (IOM), Pub. 100-04, Chapter 8 - Outpatient ESRD Hospital, Independent Facility, and Physician/Supplier Claims
Pu blicat ion s -
IRF & LTCH: Q&A Basics
M u lt im edia -
Medicare Fraud & Abuse: Prevent, Detect, Report Web-Based
View this edition as PDF (PDF)
42
Training ? Revised
PARA Weekly eJournal: August 25 2021
SPECIAL EDITION: MLN CONNECTS
43
PARA Weekly eJournal: August 25, 2021
There were 0 new or revised MedLearns released this week. To go to the full Transmittal document simply click on the screen shot or the link.
0
FIND ALL THESE MEDLEARNS IN THE ADVISOR TAB OF THE PDE
44
PARA Weekly eJournal: August 25 2021
There were EIGHT new or revised Transmittals released this week. To go to the full Transmittal document simply click on the screen shot or the link.
8
FIND ALL THESE TRANSMITTALS IN THE ADVISOR TAB OF THE PDE
45
PARA Weekly eJournal: August 25, 2021
The link to this Transmittal R10714DEMO
46
PARA Weekly eJournal: August 25 2021
The link to this Transmittal R10715DEMO
47
PARA Weekly eJournal: August 25, 2021
The link to this Transmittal R10955OTN
48
PARA Weekly eJournal: August 25 2021
The link to this Transmittal R10957OTN
49
PARA Weekly eJournal: August 25, 2021
The link to this Transmittal R10952CP
50
PARA Weekly eJournal: August 25 2021
The link to this Transmittal R10954OTN
51
PARA Weekly eJournal: August 25, 2021
The link to this Transmittal R10977OTN
52
PARA Weekly eJournal: August 25 2021
The link to this Transmittal R10953OTN
53